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INTRODUCTION 
Transdermal drug delivery means that a pharmaceutical 
compound is moved across the skin - the dermis - for 
subsequent systemic distribution. Hence, strictly 
semantically  this does not only include the more 
commonly understood “patch”, but also traditional 
subcutaneous administration by means of a hypodermic 
needle and a syringe as well as novel techniques such as 
microneedles. 
Following conventional terminology, a microneedle is a 
needle with representative parts (e.g. diameter) on the 
micrometer length scale. However, this definition is rather 
bold as it includes most of the standard hypodermic 
needles used in medical practice. Although there are many 
examples of “microneedles” with lengths of a few 
millimeters described in the literature, a common 
understanding of microneedles is that the length of the 
needle is shorter than 1 mm. What can be said is that 
microneedles are significantly smaller than ordinary 
needles, especially concerning the length. 
In recent years, attention has been drawn to a new type of 
delivery method where arrays of miniaturized needles are 
used to penetrate the skin layer. Since the needles are 
short, they do not reach the nerve-rich regions of the lower 
parts of the skin. As a consequence, the stimulus caused by 
microneedle insertion into the skin is weak and perceived 
as painless 1, 2. By combining microneedles with a patch-
like structure, a system can be realized which essentially 
has all the favorable properties of a traditional transdermal 
patch, i.e. continuous release, ease-of-use, unobtrusiveness 
and painlessness. Unlike the standard patch, a 
microneedle-based patch enables delivery of virtually any 
macromolecular drug (including insulin and vaccine). Such 
a patch would not only offer a discreet and patient-friendly 
drug administration system, but also an efficient and 
possibly safe way to administer drugs with minimum 
involvement from health-care professionals. A number of 
companies are actively developing microneedle technology 
for transdermal drug delivery 3. 
SKIN ANATOMY 
The skin is the largest organ of the human body and has 
several functions. It is a physical barrier towards the 
environment, it regulates body temperature and fluid loss, 
it conveys sensory information to the nervous system, and 
it processes immunologic information to the immune 
system. The skin can be divided into three main layers: the 
superficial epidermis, dermis and hypodermis, see figure 1. 
The epidermis is approximately 50–150 m2 thick and 
consists largely of constantly renewing, outward moving 
cells called keratinocytes. Apart for these cells, most of the 
antigen-presenting Langerhans’ cells are located in the 
epidermis. The outermost layer of the epidermis is the 
stratum corneum, a 10– 20 m2 thick layer of 15–30 
stacked, dead, cornified cells. These so-called corneocytes 
are flat, hexagon-shaped and partly overlapping cells with 
a diameter of approximately 30 m2. The cells are 
mechanically coupled to each other through special protein 
rivets and together with stacked layers of lipids they form 
an interlinked mechanical scaffold 4. The stratum corneum 
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forms the major constituent of the water barrier in the skin 
5. The dermis represents the bulk of the skin and the 
predominant components are collagen fibers and a smaller 
amount of elastin. This fibrous network gives tensile 
strength and elasticity to the skin and also provides support 
for nerve and vascular networks. 
 
Figure 1: Anatomy of skin from 28 
In the upper, papillary, region of the dermis the collagen 
fibers are small and loosely distributed. The deep, reticular 
region contains densely packed, bundled, collagen fibers 
mainly running parallel to the skin surface and along 
certain directions, called Langer’s lines.5, 6 
The dermis rests on the hypodermis (subcutis) which is 
composed of loose fatty connective tissue. Its thickness 
varies considerably over the surface of the body as well as 
between individuals 4. 
MICRONEEDLES FOR DRUG DELIVERY 
The concept of an array of miniaturized needles for drug 
delivery purposes essentially dates back to 1976 and a 
patent (filed 1971) from Gerstel and Place at Alza corp. 22. 
In this patent, a drug delivery device featuring 
miniaturized projections (i.e. microneedles) and a drug 
reservoir is claimed. 
The needles are small enough to penetrate only the stratum 
corneum and can be either solid or hollow. Delivery from 
the device may occur through diffusion or through 
convection by applying a force to the backing of the 
reservoir. Figure 8 shows a drawing from the original 
document illustrating the device. Although not fully to the 
point, some predecessors to Gerstel and Place’s patent 
exist, especially for vaccine delivery.  
 
Figure 2: The original concept of a microneedle-based transdermal patch from the patent of Gerstel and Place 1976 22. The 
device contains microneedles 12, a drug reservoir 16, adhesives 31 and optionally a rate-controlling membrane.  
To achieve physiologically relevant delivery rates, 
microneedle-based drug delivery is preferably made with 
arrays of needles over a certain area. To insert microneedle 
arrays with a large number of needles into the skin without 
using a special insertion tool (e.g. a high-velocity plunger), 
the insertion force needed to pierce the tissue has to be 
minimized. In addition, since the patch is aimed to deliver 
drugs, it should penetrate regardless of skin type or age of 
the subject, or the present humidity. All these factors may 
change the needed penetration force considerably. Thus, it 
is reasonable to believe that safety margins of 3–5 times 
may be required, demonstrated experimentally by Davis et 
al., penetration of microneedles into the skin is strongly 
linked to the interfacial area between the microneedle and 
the skin 7. A small interfacial area gives a low insertion 
force. In other words, a sharp needle, where the interfacial 
area is minimal, will penetrate the tissue better than a blunt 
needle. 
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It can be argued that an array of hollow microneedles, 
aimed for convective drug delivery, require far fewer 
needles to achieve therapeutic delivery rates. Thus, since 
fewer needles can be used, the insertion force of the 
needles does not necessarily need to be minimized. This is 
basically true. However, if a small number of needles are 
used, the delivery rate per needle needs to be higher than 
in the case of many needles. While a high flow rate may 
lead to significant flow resistance in micrometer-sized 
needle bores 8, the main fluid dynamical limitation lies in 
the tissue. 
A microneedle inserted into skin will cause a large 
deformation of the tissue around the insertion area. As a 
consequence, the tissue will be highly compressed, which 
leads to a concurrent reduction of the fluidic permeability 
in the tissue. By partially retracting the needle after 
insertion, and thus relieving the compressed tissue, the 
flow resistance is decreased 9–10. 
In summary, to achieve therapeutic delivery rates with 
microneedles without leakage, the delivery has to be made 
over a certain area using many needles. In turn, to allow 
insertion by hand, an array with many microneedles 
requires a sharp needle where the insertion force is low. 
MICRONEEDLE TYPES 
A classification for microneedles usually used in literature 
is based on the fabrication process: in-plane or out-of-
plane microneedles. In-plane microneedles (figure 3a) are 
fabricated with the shaft being parallel to substrate surface. 
The advantage of this arrangement is that the length of the 
needle can be very accurately controlled. A disadvantage is 
that it is difficult to fabricate two-dimensional arrays. Out-
of-plane microneedles (figure 3b) on the other hand, 
protrude from the substrate and are straightforward to 
fabricate in arrays. Instead, the length and high aspect-
ratios become significant challenges in the fabrication of 
these kinds of needles. Another useful point of distinction 
is whether the microneedles are solid or hollow. Hollow 
needles with a needle bore, or lumen, allow an active 
liquid transport through the microneedle.
 
                                               (a)                                                                                             (b) 
                                                                           
                            
Figure 3: (a) 6 mm long, hollow, in-plane microneedle. From Talbot and Pisano 23. (b) Individually addressable, 1.5 mm 
long, solid, out-of-plane microneedles used as electrodes. From Campbell et al. 24  
The following sections will give an overview of drug 
delivery microneedles, related fabrication techniques and 
design principles. 
1. MEMS 
Microelectromechanical Systems (MEMS) or Microsystem 
Technology (MST) refers to devices with sub-millimeter 
features. MEMS extend the fabrication techniques 
developed at the microelectronics industry to add 
mechanical structures onto microdevices. As such, MEMS 
devices can be made to interact with the surroundings, 
control fluidic flows or simply be used as small-scale 
mechanical devices. Typical MEMS devices are 4 
Estimated cost at UNICEF for disposable needle and 
syringe including safety disposal; i.e. the cost is based on 
very high volumes. 
2. Solid microneedle arrays 
One of the first microneedle arrays for drug delivery, 
although not transdermal, was presented 1993 by Dizon et 
al. 25. The array, featuring pyramidal-shaped silicon spikes 
at densities of thousands per square centimeter, represents 
one of the most basic designs of microneedles. The needles 
are etched in potassium hydroxide (KOH) solution and the 
geometry is defined by controlled undercutting of the etch 
mask in combination with the anisotropic etch rates in 
monocrystalline silicon. Through the controlled etch (with 
intersecting crystal planes); the needles have an extremely 
sharp apex with a tip radius below 100 nm 26. 
The array was used to transfect cells by coating the needles 
with foreign DNA before pressing the array onto cell 
cultures.  
3. Hollow microneedle arrays 
In contrast to solid microneedles, hollow needles offer the 
possibility of active injection of the drug into the tissue. 
The apparent advantage of this is that a considerably larger 
amount of drug can be delivered for a given time, thus 
opening for applications where relatively large amounts 
are needed to obtain a therapeutic effect. Additionally, 
pressure-driven delivery adds the possibility to precisely 
steer the flow rate and to obtain a more controlled delivery. 
The first hollow out-of-plane microneedles were presented 
by McAllister et al. in 1999 27.  
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APPLICATION: 
Microneedles have been used in many different 
applications, ranging from neurostimulation to gene 
delivery into individual cells. A common goal is to create a 
pathway to an object by physically circumventing some 
kind of barrier. In most applications this barrier is the skin. 
The rationale of using microneedles, as opposed to 
macroscale devices, is motivated either by the size of the 
target or the benefit of piercing in a minimally invasive 
manner. 
One of the earliest reported microneedles in the scientific 
literature was an out of- plane silicon needle array 
featuring 100, 1.5 mm long, needles on an area of 4.2 
mm×4.2 mm (figure 2b) 12. These extremely slender 
needles were used as electrical electrodes and designed to 
stimulate the visual cortex of the brain in order to regain 
sight. Related to this application, in-plane, microneedle 
probes have been used for activity recording and cellular 
chemostimuli of brain tissue 13, 14. Solid, out of- plane, 
microneedles have been used to penetrate the stratum 
corneum to facilitate EEG (Electroencephalogram) 
measurements for anesthesia monitoring 15, 16. Here, arrays 
of 200µm long needles were used to circumvent the 
electrically insulating layer of the skin. Similar 
microneedle probes have also been used for diagnostic 
purposes, where the needles were used for impedance 
measurements of skin lesion in order to detect skin cancer 
17. The technique is currently being commercialized by 
SciBase AB and expected to reach market in 2007–2008 18. 
Another application for microneedles is sampling of body 
fluids. Resembling the proboscis of a mosquito, Oka et al. 
fabricated a millimeter-long, jagged, hollow in-plane 
microneedle for blood collection 19. 
Sampling of interstitial fluid through capillary action has 
been demonstrated with arrays of 350m long, hollow, out-
of-plane microneedles 20. Microneedles have also been 
fabricated for microdialysis, where a hollow in-plane 
needle equipped with a semi-permeable membrane filters 
the sampled liquid 21. 
Although other application fields exist for microneedles, 
the vast majority of published microneedles concern drug 
delivery in various forms. 
VISION 
A microneedle-based drug delivery system may feature all 
the favorable properties that made the classical transdermal 
patch a success. Like the ordinary patch, the system would 
be easily attached to, for instance, the upper arm and worn 
for a shorter time while medicating. The advantages of 
such a system are: 
 Pain-free administration 
  Easy to use—OTC-compliant 
 Discreetness 
 Continuous release 
 Controlled release 
  Safer handling 
Pain-free administration: Microneedles with a length of a 
few hundred micrometers, only penetrates the superficial 
layers of the skin where the density of nerve receptors is 
low. As a consequence, insertion of microneedles into skin 
is perceived as painless. 
Easy to use: Like an ordinary transdermal patch, an 
envisioned system can be applied by the patient himself 
virtually without any training. However, to achieve this, 
special insertion tools and procedures are highly unwanted. 
Hence, the insertion force of the microneedles needs to be 
low and the insertion procedure needs to be reliable and 
robust. If this is achieved, it is reasonable to believe that 
the system, for certain medication, can be sold over the 
counter (OTC). 
Discreetness: Incorporating a microneedle-array with a 
planar and compact dosing system yields a patch-like, 
unobtrusive device that can be discreetly worn under 
clothing. 
Continuous release: An unobtrusive device may be worn 
for longer times, thus enabling continuous and sustained 
delivery at therapeutic levels. 
Controlled release: Drug release through a separate 
mechanism allows the release rate to be precisely 
controlled. This may be accomplished through integration 
of passive elements, e.g. flow restrictors or membranes, or 
active devices. Active dosing systems offer the possibility 
to modulate the delivery in time and in amplitude. Even 
more advanced, active elements permit the use of closed-
loop systems. 
Safer handling: Microneedles protruding a few hundred 
micrometers from a surface pose a far less risk of 
accidental needle sticks than hypodermic needles do. Since 
microneedles do not reach into the blood, the risk of 
transmission of blood-borne pathogens is also further 
reduced. 
CONCLUSION 
The microneedles require a very low insertion force to be 
inserted into skin, potentially allowing arrays with 
hundreds of such microneedles to be inserted into skin by 
hand without any aids. It can penetrate human skin in vivo 
at clinically relevant sites. It can be hermetically sealed 
through thin membranes and be opened at the time of 
delivery by applying pressure or inserting the sealed 
needles into skin tissue. It can be fabricated with high 
process yield.Microneedles also combines the advantages 
of transdermal patch as well as needles.  
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